Basic and Clinical Science

News
May 19, 2020

It’s not an AIDS vaccine but it may be the closest thing to one so far. A long-acting antiretroviral drug given as an injection every 2 months powerfully protected uninfected people from HIV in a large-scale study that was disrupted by the COVID-19 pandemic.

Resource
May 18, 2020

Background: 

Men living with HIV (MLHIV) have a high burden of human papillomavirus (HPV)-related cancer. Understanding serological dynamics of HPV in men can guide decisions on introducing HPV vaccination and monitoring impact.

News
May 13, 2020

With the rapid spread of COVID-19 across Africa, m2m President & CEO, Frank Beadle de Palomo, looks at how countries and organisations are harnessing lessons learned from the HIV/AIDS response to mitigate the impact of this new pandemic.

Event
May 7, 2020

The COVID-19 pandemic represents an unprecedented global emergency that has now infected more than 3 million people worldwide and is already the most lethal new pandemic since the emergence of AIDS nearly 40 years ago.

Resource
May 6, 2020

The HIV pandemic provides lessons for the response to the novel coronavirus disease 2019 (COVID-19) pandemic: no vaccine is available for either and there are no licensed pharmaceuticals for COVID-19, just as there was not for HIV infection in the early years.

Resource
May 4, 2020

Status

Ongoing

Phase

Demo Project

Objective

Resource
April 30, 2020

Coronaviruses are important causes of infection in both humans and animals.

Resource
April 23, 2020

This edition of HIV Nursing Matters introduces one of the most exciting and highly anticipated antiretroviral (ARV) drugs to enter the HIV treatment space.

News
April 8, 2020

South Africa has spent the last two decades fighting against its deadly HIV and TB epidemics, and many of its HIV researchers are now mustering their expertise to battle the Covid-19 pandemic.The scientific community has “galvanized” to investigate the novel coronavirus and the disease it causes,